Willi Sauerbrei

Willi Sauerbrei's AcademicInfluence.com Rankings

Willi Sauerbrei

Computer Science

#6496

World Rank

#6849

Historical Rank

Information Technology

#44

World Rank

#45

Historical Rank

Data Science

#127

World Rank

#130

Historical Rank

Machine Learning

#2130

World Rank

#2158

Historical Rank

computer-science Degrees

Willi Sauerbrei

Mathematics

#6566

World Rank

#9071

Historical Rank

Statistics

#629

World Rank

#712

Historical Rank

Measure Theory

#1433

World Rank

#1798

Historical Rank

mathematics Degrees

Download Badge

Computer Science
Mathematics

Why Is Willi Sauerbrei Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Willi Sauerbrei's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
Reporting recommendations for tumor marker prognostic studies (REMARK). (2005) (2075)
Dichotomizing continuous predictors in multiple regression: a bad idea (2006) (1866)
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. (1994) (1100)
The use of fractional polynomials to model continuous risk variables in epidemiology. (1999) (1060)
Multivariable Model-Building: A Pragmatic Approach to Regression Analysis based on Fractional Polynomials for Modelling Continuous Variables (2008) (807)
Reporting recommendations for tumor marker prognostic studies. (2005) (787)
Selection of important variables and determination of functional form for continuous predictors in multivariable model building (2007) (785)
Assessment and comparison of prognostic classification schemes for survival data. (1999) (709)
A bootstrap resampling procedure for model building: application to the Cox regression model. (1992) (597)
REporting recommendations for tumour MARKer prognostic studies (REMARK) (2005) (543)
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration (2012) (536)
REporting recommendations for tumor MARKer prognostic studies (REMARK) (2005) (534)
A new measure of prognostic separation in survival data (2004) (395)
Prognosis research strategy (PROGRESS) 4: Stratified medicine research (2013) (385)
REporting recommendations for tumour MARKer prognostic studies (REMARK) (2006) (375)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012) (335)
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. (2002) (334)
Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs (2006) (317)
The Use of Resampling Methods to Simplify Regression Models in Medical Statistics (1999) (315)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration (2018) (265)
A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials (2004) (255)
Multivariable Modeling with Cubic Regression Splines: A Principled Approach (2007) (218)
A review of spline function procedures in R (2019) (216)
Building Multivariable Regression Models with Continuous Covariates in Clinical Epidemiology (2005) (200)
Multivariable model-building (2008) (194)
REporting recommendations for tumour MARKer prognostic studies (REMARK). (2005) (189)
Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. (1996) (163)
Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. (2000) (149)
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group. (1994) (146)
Resampling and cross-validation techniques: a tool to reduce bias caused by model building? (1997) (143)
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses (2020) (141)
Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer. (2003) (137)
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond (2009) (132)
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines (2009) (122)
Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation (2003) (110)
Sample size considerations for the evaluation of prognostic factors in survival analysis. (2000) (108)
Multivariate Analysis of Prognostic Factors in Patients with Glioblastoma (2003) (102)
Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) (2003) (101)
Stability Investigations of Multivariable Regression Models Derived from Low- and High-Dimensional Data (2011) (95)
STRengthening Analytical Thinking for Observational Studies: the STRATOS initiative (2014) (94)
Modelling the effects of standard prognostic factors in node-positive breast cancer (1999) (93)
Confidence intervals for the effect of a prognostic factor after selection of an ‘optimal’ cutpoint (2004) (92)
A New Proposal for Multivariable Modelling of Time‐Varying Effects in Survival Data Based on Fractional Polynomial Time‐Transformation (2007) (87)
Identification of clinically useful cancer prognostic factors: what are we missing? (2005) (87)
Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response (2013) (84)
State of the art in selection of variables and functional forms in multivariable analysis—outstanding issues (2019) (80)
State of the art in selection of variables and functional forms in multivariable analysis—outstanding issues (2019) (80)
Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales (1994) (79)
Individual participant data meta-analysis of prognostic factor studies: state of the art? (2012) (77)
Preoperative staging of breast cancer by palpation, mammography and high‐resolution ultrasound (1993) (76)
Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence. (2010) (73)
Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer. (1997) (72)
Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. (2004) (72)
On the necessity and design of studies comparing statistical methods (2018) (67)
Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group. (2003) (66)
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF (2002) (64)
Subsampling versus bootstrapping in resampling‐based model selection for multivariable regression (2016) (63)
Color Doppler and duplex flow analysis for classification of breast lesions. (1997) (63)
Added predictive value of high-throughput molecular data to clinical data and its validation (2011) (57)
Color Doppler flow criteria of breast lesions. (1994) (57)
Tumor-Cell Number and Viability as Quality and Efficacy Parameters of Autologous Virus-Modified Cancer Vaccines in Patients With Breast or Ovarian Cancer (1997) (56)
Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects. (1992) (54)
Improving the robustness of fractional polynomial models by preliminary covariate transformation: A pragmatic approach (2007) (54)
Interactions between treatment and continuous covariates: a step toward individualizing therapy. (2008) (54)
MFP: Multivariable Model‐Building with Fractional Polynomials (2008) (54)
Bootstrap Assessment of the Stability of Multivariable Models (2009) (53)
Value of sonomorphological criteria of the endometrium in women with postmenopausal bleeding: a multivariate analysis (2002) (50)
Two Techniques for Investigating Interactions between Treatment and Continuous Covariates in Clinical Trials (2009) (46)
The practical utility of incorporating model selection uncertainty into prognostic models for survival data (2005) (45)
On stability issues in deriving multivariable regression models (2015) (45)
The prognostic effect of histological tumor grade in node-negative breast cancer patients (2004) (42)
Modelling continuous exposures with a ‘spike’ at zero: A new procedure based on fractional polynomials (2010) (42)
A new strategy for meta‐analysis of continuous covariates in observational studies (2011) (41)
Investigating the prediction ability of survival models based on both clinical and omics data: two case studies (2014) (41)
A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer. (1995) (41)
Modeling the effects of continuous risk factors. (2000) (40)
Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). (1998) (40)
The prognostic effect of histological tumour grade in node-negative breast cancer patients (1993) (39)
Cellular DNA content and survival in advanced ovarian carcinoma (1994) (39)
Human papillomavirus DNA in cervical carcinoma—correlation with clinical data and influence on prognosis (1994) (38)
Cross-Validation, Shrinkage and Variable Selection in Linear Regression Revisited (2013) (38)
Prognostic factors. Confusion caused by bad quality design, analysis and reporting of many studies. (2005) (37)
Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. (1995) (37)
CA-125 serum concentrations during the menstrual cycle. (1988) (37)
Is treatment with interferon-α effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions (2004) (35)
Comparison of procedures to assess non‐linear and time‐varying effects in multivariable models for survival data (2011) (34)
Interaction of treatment with a continuous variable: simulation study of significance level for several methods of analysis (2013) (33)
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles (2017) (33)
Classification of adnexal tumors by transvaginal color Doppler. (1996) (33)
Detecting an interaction between treatment and a continuous covariate: A comparison of two approaches (2007) (32)
Continuous-wave and pulsed Doppler studies of the breast: clinical results and effect of transducer frequency. (1991) (32)
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer (2018) (31)
Evidence-Based Assessment and Application of Prognostic Markers: The Long Way from Single Studies to Meta-Analysis (2006) (31)
Facilitating harmonized data quality assessments. A data quality framework for observational health research data collections with software implementations in R (2020) (30)
Interaction of treatment with a continuous variable: simulation study of power for several methods of analysis (2014) (30)
Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF. (2001) (29)
On properties of predictors derived with a two-step bootstrap model averaging approach - A simulation study in the linear regression model (2008) (29)
Quantitative flow measurements for classification of ovarian tumors by transvaginal color Doppler sonography in postmenopausal patients (1994) (29)
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: an update based on 10 years' follow-up. German Breast Cancer Study Group. (2000) (28)
Validation of existing and development of new prognostic classification schemes in node negative breast cancer (2004) (28)
Validation of existing and development of new prognostic classification schemes in node negative breast cancer (2004) (27)
Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival. (2004) (26)
Differentiation of Benign and Malignant Breast Tumors by Logistic Regression and a Classification Tree using Doppler flow signals (1998) (26)
Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease☆☆☆ (1997) (26)
Global, Parameterwise and Joint Shrinkage Factor Estimation (2016) (22)
Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis. (1994) (21)
Prognostic Factor Studies (2012) (19)
Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia (2019) (19)
Modeling Variables With a Spike at Zero: Examples and Practical Recommendations (2017) (19)
Investigation about a screening step in model selection (2008) (18)
Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up (2019) (17)
Therapy of small breast cancer - four-year results of a prospective non-randomized study (1995) (17)
Diagnostic formula for the differentiation of adnexal tumors by transvaginal sonography (1997) (17)
Modelling to extract more information from clinical trials data: On some roles for the bootstrap (2007) (16)
Variable Selection and Shrinkage: Comparison of Some Approaches (2001) (16)
Introduction to statistical simulations in health research (2020) (16)
Analysing covariates with spike at zero: A modified FP procedure and conceptual issues (2012) (16)
Co‐expression of M‐CSF transcripts and protein, FMS (M‐CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary (1994) (16)
Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example (2016) (16)
Multivariable fractional polynomial interaction to investigate continuous effect modifiers in a meta-analysis on higher versus lower PEEP for patients with ARDS (2016) (16)
Investigation on the Improvement of Prediction by Bootstrap Model Averaging (2006) (15)
The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. (1998) (15)
Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients (1995) (15)
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer (2018) (14)
Differential diagnosis of breast lesions by color Doppler (1995) (14)
Multivariable model-building with continuous covariates : 1 . Performance measures and simulation design (2011) (14)
Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node‐positive breast‐cancer patients (2000) (14)
Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review (2018) (14)
Estrogen and progesterone receptors in ovarian neoplasms: discrepant results of immunohistochemical and biochemical methods (1991) (14)
An Experimental Evaluation of Boosting Methods for Classification (2010) (14)
Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer (2002) (14)
Multivariate analysis of flow data in breast lesions and validation in a normal clinical setting. (2010) (13)
[Therapy of hypopharyngeal cancer. Part IV: Long-term results of transoral laser microsurgery of hypopharyngeal cancer]. (1994) (13)
Long-Term Follow-Up of Patients in Four Prospective Studies of the German Breast Cancer Study Group (GBSG): A Summary of Key Results (2002) (13)
Breast preservation versus mastectomy in early breast cancer--1991 update of the GBSG 1--protocol and prognostic factors. The German Breast Cancer Study Group. (1992) (13)
Timing of breast cancer surgery--some arguments that there is no effect. (1994) (13)
Quality control review for radiotherapy of small breast cancer: analysis of 708 patients in the GBSG I trial. German Breast Study Group (GBSG). (1993) (13)
Steroid receptors in ovarian carcinoma: Immunohistochemical determination may lead to new aspects (1993) (12)
Meta‐analysis of non‐linear exposure‐outcome relationships using individual participant data: A comparison of two methods (2018) (12)
Information from CTC measurements for metastatic breast cancer prognosis—we should do more than selecting an “optimal cut point” (2010) (12)
Human papillomavirus DNA in tumor-free regional lymph nodes: a potential prognostic marker in cervical carcinoma. (1996) (11)
On Statistical Approaches for the Multivariable Analysis of Prognostic Marker Studies (2007) (10)
Tumor stage and early mortality for surgical resections in lung cancer (2003) (10)
DNA flow cytometry in node-positive breast cancer. Prognostic value and correlation with morphologic and clinical factors. (1995) (10)
Stability analysis of an additive spline model for respiratory health data by using knot removal (2009) (9)
On Fishing for Significance and Statistician’s Degree of Freedom in the Era of Big Molecular Data (2017) (9)
Prognostic effect of timing of surgery during menstrual cycle in premenopausal breast‐cancer patients (1994) (9)
CONTINUOUS VARIABLES: TO CATEGORIZE OR TO MODEL? (2010) (9)
A plea for taking all available clinical information into account when assessing the predictive value of omics data (2019) (8)
Combining clinical and molecular data in regression prediction models: insights from a simulation study (2019) (8)
Handling interactions in Stata, especially with continuous predictors (2012) (8)
REMARK (REporting Recommendations for Tumor MARKer Prognostic Studies) (2014) (8)
Modeling continuous covariates with a “spike” at zero: Bivariate approaches (2016) (8)
Prognostic factor research (2019) (8)
Adding local components to global functions for continuous covariates in multivariable regression modeling (2010) (8)
The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. German Breast Cancer Study Group. (1998) (7)
[Analysis of a method for Doppler study of the female breast]. (2008) (7)
A note on estimating local recurrence rates in clinical trials on the treatment of breast cancer (1998) (7)
Wiley Series in Probability and Statistics (2008) (7)
DNA flow cytometry in stage IB and II cervical carcinoma (1995) (7)
Selection of Variables (2008) (7)
Use of pretransformation to cope with extreme values in important candidate features (2011) (6)
Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example (2016) (6)
Mfpa: Extension of mfp Using the ACD Covariate Transformation for Enhanced Parametric Multivariable Modeling (2016) (6)
Investigation of continuous effect modifiers in a meta-analysis on higher versus lower PEEP in patients requiring mechanical ventilation - protocol of the ICEM study (2014) (6)
Estimating the Effect of a Prognostic or Risk Factor after Selection of an " Optimal " Cutpoint (2001) (5)
A Measure for Assessing Functions of Time-Varying Effects in Survival Analysis (2014) (5)
Increasing the usefulness of additive spline models by knot removal (2008) (5)
Modeling exposures with a spike at zero: simulation study and practical application to survival data (2019) (5)
Review of guidance papers on regression modeling in statistical series of medical journals (2022) (5)
[Differential breast diagnosis using CW-Doppler ultrasound]. (1990) (5)
Multivariable Fractional Polynomial Models (2016) (5)
Exploration of the variability of variable selection based on distances between bootstrap sample results (2019) (5)
Dose–response modelling for bivariate covariates with and without a spike at zero: theory and application to binary outcomes (2015) (5)
Re: Reporting recommendations for tumor marker prognostic studies (REMARK) - Reply (2005) (5)
REporting recommendations for tumor MARKer prognostic studies (REMARK). (2005) (5)
Detection of influential points as a byproduct of resampling-based variable selection procedures (2017) (4)
On alcohol consumption and all-cause mortality (2001) (4)
Randomized study comparing carboplatin/cyclophosphamide and cisplatin/cyclophosphamide as first-line treatment in patients with stage III/IV epithelial ovarian cancer and small volume disease. German Ovarian Cancer Study Group (GOCA). (1997) (4)
Relationship between epidermal growth factor receptor (EGF-R) and various prognostic factors in human endometrial carcinoma (1991) (4)
Sonographic Detection of Occult Tumor Extension (1994) (4)
Handling co-dependence issues in resampling-based variable selection procedures: a simulation study (2018) (4)
Exaggeration of the prognostic effect of Mammostrat: a consequence of poor reporting? (2013) (4)
Multivariable model-building with continuous covariates : 2 . Comparison between splines and fractional polynomials (2011) (4)
Comparison of variable selection procedures and investigation of the role of shrinkage in linear regression-protocol of a simulation study in low-dimensional data (2022) (4)
[Initial results of the Project of the German Breast Cancer Study Group on "Breast saving therapy of the small breast cancer"]. (1992) (4)
Fractional Polynomials for One Variable (2008) (4)
Diagnostic tools and prognostic factors in human breast cancer evaluated by morphological and immunohistochemical methods (1992) (4)
The use of fractional polynomials to model interactions between treatment and continuous covariates in clinical trials (2002) (3)
Effect of radiotherapy in addition to 6 cycles CMF in node positive breast cancer patients (1998) (3)
Guidance for designing and analysing observational studies: The strengthening analytical thinking for observational studies (STRATOS) initiative (2017) (3)
Doug Altman: Driving critical appraisal and improvements in the quality of methodological and medical research (2020) (3)
Comment on ‘BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses' (2018) (3)
Aspekte der statistischen Evaluation neuer Prognosefaktoren: Illustration bei Studien in der Onkologie (1999) (3)
Bootstrap and Cross-Validation to Assess Complexity of Data-Driven Regression Models (2000) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Rhythmic fluctuations of CEA serum levels in breast cancer patients. (1987) (3)
Structured reporting to improve transparency of analyses in prognostic marker studies (2022) (3)
Importance of the distinction between quality of methodology and quality of reporting. (2017) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients (2001) (2)
On approaches for modelling time-varying effects in survival analysis (2008) (2)
MODELLING INTERACTIONS WITH CONTINUOUS VARIABLES (2010) (2)
Color Doppler Flow Assessment of Breast Disease (1994) (2)
The German Breast Preservation Trial. Concept and first results related to the structural relationship of various prognostic factors (1990) (2)
Systematic review of education and practical guidance on regression modeling for medical researchers who lack a strong statistical background: Study protocol (2020) (2)
Treatment of Primary Breast Cancer at the Surgical Unit of the Charité 1984-1998 (2013) (2)
Updated survival results from the Zebra trial. (2002) (2)
On the Development and Validation of Classification Schemes in Survival Data (1997) (2)
Determination of Functional Relationships for Continuous Variables by Using a Multivariable Fractional Polynomial Approach (2002) (2)
THE IMPORTANCE OF BASIC STATISTICAL PRINCIPLES FOR THE INTERPRETATION OF EPIDEMIOLOGICAL DATA (1997) (2)
The Multivariable Fractional Polynomial Approach , with Thoughts about Opportunities and Challenges in Big Data (2016) (2)
Faculty of 1000 evaluation for Reporting performance of prognostic models in cancer: a review. (2011) (1)
Special Topics Involving Fractional Polynomials (2008) (1)
Detecting an interaction between treatment and a continuous covariate : a comparison between two approaches (2006) (1)
Duration of adjuvant chemotherapy for breast cancer: A joint analysis of two randomized trials investigating 3 versus 6 courses of CMF (cyclophosphamide, methotrexate and 5-fluorouracil) (2002) (1)
[24-hour CA 15/3 serum concentrations in patients with primary and metastasizing breast cancer]. (1987) (1)
32 Building multivariable prognostic models: Transformation of the predictors using fractional polynomials (1997) (1)
Therapy of small breast cancer — comparision between mastectomy and breast preserving therapy (1991) (1)
Management of Data in Clinical Trials. Eleanor McFadden, Wiley, 1998. No. of pages: xi+210. Price: £50. ISBN 0‐471‐30316‐X (1999) (1)
Comments on ‘Performance of using multiple stepwise algorithms for variable selection’ by Ryan E. Wiegand, Statistics in Medicine 2010; 29:1647–1659 (2011) (1)
Investigating treatment-effect modification by a continuous covariate in IPD meta-analysis: an approach using fractional polynomials (2022) (1)
Some Comparisons of MFP with Splines (2008) (1)
Comment on: Reporting recommendations for tumor marker prognostic studies (REMARK). Authors' reply (2005) (1)
Exploration of the variability of variable selection based on distances between bootstrap sample results (2019) (1)
O-12 Radiation therapy after breast-conserving surgery: randomised trial in patients with low risk of recurrence (2007) (1)
Faculty Opinions recommendation of Trials in primary care: statistical issues in the design, conduct and evaluation of complex interventions. (2010) (1)
Pulmonary Function in Coronary Heart Disease and Valve Disease (1988) (0)
Contents, Vol. 20, 1997 (1997) (0)
How To Work with MFP (2008) (0)
A randomized clinical trial evaluating the duration of chemotherapy in patients with primary, node-positive breast cancer (1993) (0)
Is Aphasia a Significant Prognostic Factor for the Recovery of Function After Ischemic Stroke Causing Hemiparesis? (1989) (0)
S37.2: Comparison of predictors in the linear regression model: Improvement by bootstrap averaging? (2004) (0)
Determinants of prognosis after first isolated locoregional recurrence of breast cancer (1998) (0)
Toward a Comprehensive, Integrated Framework for Advanced Statistical Analyses of Observational Studies (19w5198) (2019) (0)
Education for Statistics in Practice (2010) (0)
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice. (2023) (0)
Methodological aspects of diagnostic models of atopic dermatitis (1993) (0)
Response to Katz and Kattan (2006) (0)
Overinterpretation and misreporting of prognostic factor studies in medical oncology (2016) (0)
BBS Seminar IPD meta-analysis of treatment-covariate interaction with a continuous predictor (2013) (0)
University of Birmingham Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? (2017) (0)
Statistical aspects in the analysis of a breast cancer clinical trial (1991) (0)
Comparison of 3 versus 6 cycles CMF in node positive breast cancer patients based on 10 years follow-up (1998) (0)
EVALUATING CLINICAL EVIDENCE: A HANDBOOK FOR MANAGERS. (1996) (0)
Re: Meta-analysis comparing cisplatin total dose intensity and survival: a critical reappraisal. (1996) (0)
Faculty Opinions recommendation of Recent developments in meta-analysis. (2009) (0)
Interaction of treatment with a continuous variable: Comparison of approaches and an IPD meta-analysis to summarize results across several studies (2014) (0)
S41.3: Modelling time‐varying effects in survival data (2004) (0)
REporting recommendations for tumor MARKer prognostic studies (REMARK). (2005) (0)
Use of Resampling Procedures to Investigate Issues of Model Building and Its Stability (2019) (0)
Investigating interactions in multivariable model-building with continuous covariates (2008) (0)
Abstract P2-11-01: Effects of radiotherapy on breast cancer outcomes among stage I, low-Recurrence risk, hormone-Sensitive breast cancer: Pooled analysis of individual data from phase III trials (2018) (0)
Faculty Opinions recommendation of Evaluation of networks of randomized trials. (2009) (0)
Response to “How to judge a tumor marker” Katz and Kattan (2005) (0)
Updated survival analyses from the ZEBRA study: goserelin vs CMF in premenopausal women with node-positive breast cancer (2003) (0)
STRATOS News vol. 1 (2018) (0)
Investigations on Stability and Overoptimism of Classification Trees by Using Cross-Validation (2001) (0)
Some Issues with Univariate Fractional Polynomial Models (2008) (0)
Title : Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania Version : 2 (0)
Comment on ‘BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses' (2018) (0)
Faculty Opinions recommendation of Almost all articles on cancer prognostic markers report statistically significant results. (2008) (0)
Subject Index Vol. 20, 1997 (1997) (0)
PLASMA TRYPTOPHAN A BIOCHEMICAL MARKER OF SUICIDE BEHAVIOUR (1987) (0)
Effects of influential points and sample size on the selection and replicability of multivariable fractional polynomial models (2022) (0)
REMARK guidelines for tumour biomarker study reporting: a remarkable history (2022) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Autorenregister Vol. 36, 1996 (2004) (0)
[Combined evaluation of ovarian tumors with transvaginal B-image and color Doppler ultrasound]. (1996) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Basic Statistical Principles for the Evaluation of Risk Factors (1994) (0)
Contents Vol. 36, 2013 (2013) (0)
Exhuming nonnegative garrote from oblivion using suitable initial estimates- illustration in low and high-dimensional real data (2022) (0)
Use of Crossvalidation to Assess Diagnostic Classification Schemes of Atopic Dermatitis (1997) (0)
Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review (2018) (0)
[Transvaginal color-coded Doppler ultrasound in ovarian tumors]. (1994) (0)
712 Evaluation of Cardiotoxicity via Speckle-Tracking Echocardiography in Patients Treated with Anthracyclines (2015) (0)
Band 25, Heft 2, April 2002 (2002) (0)
The influence of categorizing survival time on parameter estimates in a Cox model (2007) (0)
Statistical models for complex data in clinical and epidemiological research (2020) (0)
O-3 Long-term results from the ZEBRA trial comparing Goserelin with CMF as adjuvant therapy in premenopausal women (2007) (0)
Prognostic impact of HER-2/neu gene copy number determination by fluorescence in situ hybridisation (FISH) versus immunohistochemically detected overexpression in node positive primary breast cancer (1998) (0)
Appendix A: Data and Software Resources (2008) (0)
Handling Categorical and Continuous Predictors (2008) (0)
Appendix B: Glossary of Abbreviations (2008) (0)
Education for biometry in practice (2018) (0)
[Adjuvant chemotherapy of breast cancer with the CMFV protocol]. (1990) (0)
Statistical aspects of the development and validation of a diagnostic score (1994) (0)
Developing a Comprehensive, Integrated Framework for Advanced Statistical Analyses of Observational Studies (2016) (0)
14th Annual Meeting Oberrheinische Arbeitsgemeinschaft für Onkologie (OAO). Groupe de Travail des Oncologues du Rhin Supérieur (GTOR), Metz, February 6–7, 1998 (1997) (0)
Sachregister Vol. 36, 1996 (1996) (0)
A method for IPD meta-analysis of treatment-covariate interaction with a continuous predictor in randomised trials (2014) (0)
[Champagne administered by spoon for peritonitis after cesarean section. From the history of obstetrics in Erlangen--data from about 60,000 deliveries in 100 years]. (1996) (0)
Overinterpretation and misreporting of prognostic factor and biomarker studies in medical oncology. (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Willi Sauerbrei?

Willi Sauerbrei is affiliated with the following schools:

University of Freiburg

Willi Sauerbrei's Academic­Influence.com Rankings

Why Is Willi Sauerbrei Influential?

Willi Sauerbrei's Published Works

Published Works

What Schools Are Affiliated With Willi Sauerbrei?

Willi Sauerbrei's AcademicInfluence.com Rankings